Roles of mitochondrial DNA in dynamics of the immune response to COVID-19

被引:11
作者
Mahmoodpoor, Ata [1 ]
Sanaie, Sarvin [1 ]
Ostadi, Zoherh [2 ]
Eskandari, Maqsoud [2 ]
Behrouzi, Nazila [2 ]
Asghari, Roqayyeh [2 ]
Zahirnia, Ahmad [3 ]
Sohrabifar, Nasim [4 ]
Kazeminasab, Somayeh [3 ,5 ]
机构
[1] Tabriz Univ Med Sci, Res Ctr Integrat Med Aging, Aging Res Inst, Tabriz, Iran
[2] Tabriz Univ Med Sci, Fac Med, Dept Anesthesiol & Intens Care, Tabriz, Iran
[3] Nasle Farda Hlth Fdn, Med Genet Lab, Tabriz, Iran
[4] Shahid Beheshti Univ Med Sci, Cardiovasc Res Ctr, Tehran, Iran
[5] Tabriz Univ Med Sci, Fac Med, Dept Med Genet, Tabriz, Iran
关键词
mtDNA; ccf-mtDNA; Immune response; Inflammasome; COVID-19; SARS-CoV-2; NLRP3; INFLAMMASOME; LUNG INJURY; CGAS; SARS-COV-2; INFECTION; DISEASE; MAVS; ACTIVATION; MECHANISMS; INSIGHTS;
D O I
10.1016/j.gene.2022.146681
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mitochondria dynamics have a pivotal role in many aspects of immune function. Viral infections affect mitochondrial dynamics and trigger the release of mitochondrial DNA (mtDNA) in host cells. Released mtDNA guides the immune response towards an inflammatory response against pathogens. In addition, circulating cell-free mtDNA (ccf-mtDNA) is considered an invaluable indicator for the prognosis and severity of infectious diseases. This study provides an overview of the role of mtDNA in the dynamics of the immune response to COVID-19. We focused on the possible roles of mtDNA in inducing the signaling pathways, and the inflammasome activation and regulation in SARS-CoV-2. Targeting mtDNA-related pathways can provide critical insights into therapeutic strategies for COVID-19.
引用
收藏
页数:7
相关论文
共 99 条
[1]   Regulation of cGAS- and RLR-mediated immunity to nucleic acids [J].
Ablasser, Andrea ;
Hur, Sun .
NATURE IMMUNOLOGY, 2020, 21 (01) :17-29
[2]   cGAS in action: Expanding roles in immunity and inflammation [J].
Ablasser, Andrea ;
Chen, Zhijian J. .
SCIENCE, 2019, 363 (6431) :1055-+
[3]   NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity [J].
Amin, Saiful ;
Aktar, Salma ;
Rahman, Md Mijanur ;
Chowdhury, Mohammed Mehadi Hassan .
MICROBES AND INFECTION, 2022, 24 (01)
[4]   Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19 [J].
Angelopoulou, Athina ;
Alexandris, Nikos ;
Konstantinou, Evangelia ;
Mesiakaris, Konstantinos ;
Zanidis, Charilaos ;
Farsalinos, Konstantinos ;
Poulas, Konstantinos .
ENVIRONMENTAL RESEARCH, 2020, 188
[5]   Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19 [J].
Babajani, Amirhesam ;
Hosseini-Monfared, Pooya ;
Abbaspour, Samin ;
Jamshidi, Elham ;
Niknejad, Hassan .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[6]   Circulating Cell-Free mtDNA Contributes to AIM2 Inflammasome-Mediated Chronic Inflammation in Patients with Type 2 Diabetes [J].
Bae, Jung Hwan ;
Jo, Seung, II ;
Kim, Seong Jin ;
Lee, Jong Min ;
Jeong, Ji Hun ;
Kang, Jeong Suk ;
Cho, Nam-Jun ;
Kim, Sang Soo ;
Lee, Eun Young ;
Moon, Jong-Seok .
CELLS, 2019, 8 (04)
[7]   Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA [J].
Barton, GM ;
Kagan, JC ;
Medzhitov, R .
NATURE IMMUNOLOGY, 2006, 7 (01) :49-56
[8]   Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter [J].
Belgnaoui, S. Mehdi ;
Paz, Suzanne ;
Hiscott, John .
CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (05) :564-572
[9]  
Bezemer G.F., 1958, FRONT PHARMACOL, V11
[10]   Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity [J].
Burtscher, Johannes ;
Cappellano, Giuseppe ;
Omori, Akiko ;
Koshiba, Takumi ;
Millet, Gregoire P. .
ISCIENCE, 2020, 23 (10)